Delivery Order SPE2DB25D3003-SPE2DB25FPVFL

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $22K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVFL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The firm-fixed-price delivery order, valued at $21,715.54, has a completion date of November 20, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/18/25, 1:35 PM